Optimization of plasmid vectors for high-level expression in lung epithelial cells

Human Gene Therapy

Volumn 8, Issue 5, 1997, Pages 575-584

  Yew, Nelson S ^a   Wysokenski, Donna M ^a   Wang, Kathryn X ^a   Ziegler, Robin J ^a   Marshall, John ^a   Mcneilly, Dave ^a   Cherry, Maribeth ^a   Osburn, William ^a   Cheng, Seng H ^a  

^a GENZYME CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; GROWTH HORMONE; PLASMID DNA; PLASMID VECTOR; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENHANCER REGION; GENE EXPRESSION; GENE TRANSFER; HUMAN CYTOMEGALOVIRUS; IMMEDIATE EARLY GENE; INTRON; LUNG ALVEOLUS EPITHELIUM; MOUSE; NONHUMAN; POLYADENYLATION; PROMOTER REGION; RABBIT; RECOMBINANT GENE;

EID: 0030996180     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.5-575     Document Type: Article

References (48)

1. ABE, M., and KUFE, D. (1993). Characterization of cis-acting elements regulating transcription of the human DF3 breast carcinoma-associated antigen (MUC1) gene. Proc. Natl. Acad. Sci. USA 90, 282-286.
2. BAKER, R.T., and BOARD, P.G. (1987). The human ubiquitin gene family: structure of a gene and pseudogenes from the Ub B subfamily. Nucleic Acids Res. 15, 443-463.
3. BERGER, J., HAUBER, J., HAUBER, R., GEIGER, R., and CULLEN, B.R. (1988). Secreted placental alkaline phosphatase: A powerful new quantitative indicator of gene expression in eukaryotic cells. Gene 66, 1-10.
4. CAPLEN, N.J., ALTON, E.W., MIDDLETON, P.G., DORIN, J.R., STEVENSON, B.J., GAO, X., DURHAM, S.R., JEFFERY, P.K., HODSON, M.E., COUTELLE, C., HUANG, L., PORTEOUS, D.J., WILLIAMSON, R., and GEDDES, D.M. (1995). Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Med. 1, 39-46.
5. CARSWELL, S., and ALWINE, J.C. (1989). Efficiency of utilization of the simian virus 40 late polyadenylation site: effects of upstream sequences. Mol. Cell. Biol. 9, 4248-4258.
6. CHAPMAN, B.S., THAYER, R.M., VINCENT, K.A., and HAIGWOOD, N.L. (1991). Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. Nucleic Acids Res. 19, 3979-3986.
7. CHENG, L., ZIEGELHOFFER, P.R., and YANG, N.S. (1993). In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. Proc. Natl. Acad. Sci. USA 90, 4455-4459.
8. CHOI, T., HUANG, M., GORMAN, C., and JAENISCH, R. (1991). A generic intron increases gene expression in transgenic mice. Mol. Cell. Biol. 11, 3070-3074.
9. FELGNER, J.H., KUMAR, R., SRIDHAR, C.N., WHEELER, C.J., TSAI, Y.J., BORDER, R., RAMSEY, P., MARTIN, M., and FELGNER, P.L. (1994). Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J. Biol. Chem. 269, 2550-2561.
10. FELGNER, P.L., TSAI, Y.J., SUKHU, L., WHEELER, C.J., MANTHORPE, M., MARSHALL, J., and CHENG, S.H. (1995). Improved cationic lipid formulations for in vivo gene therapy. Ann. N.Y. Acad. Sci. 772, 126-139.
11. FOECKING, M.K., and HOFSTETTER, H. (1986). Powerful and versatile enhancer-promoter unit for mammalian expression vectors. Gene 45, 101-105.
12. GAO, X., and HUANG, L. (1995). Cationic liposome-mediated gene transfer. Gene Ther. 2, 710-722.
13. GAO, X., and HUANG, L. (1996). Potentiation of cationic liposome-mediated gene delivery by polycations. Biochemistry 35, 1027-1036.
14. GOODWIN, E.C., and ROTTMAN, F.M. (1992). The 3′-flanking sequence of the bovine growth hormone gene contains novel elements required for efficient and accurate polyadenylation. J. Biol. Chem. 267, 16330-16334.
15. GOSSEN, M., and BUJARD, H. (1992). Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89, 5547-5551.
16. GUO, F.H., DE-RAEVE, H.R., RICE, T.W., STUEHR, D.J., THUNNISSEN, F.B., and ERZURUM, S.C. (1995). Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc. Natl. Acad. Sci. USA 92, 7809-7813.
17. GUY-CAFFEY, J.K., BODEPUDI, V., BISHOP, J.S., JAYARAMAN, K., and CHAUDHARY, N. (1995). Novel polyaminolipids enhance the cellular uptake of oligonucleotides. J. Biol. Chem. 270, 31391-31396.
18. HARMS, J.S., and SPLITTER, G.A. (1995). Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter. Hum. Gene Ther. 6, 1291-1297.
19. HARTIKKA, J., SAWDEY, M., CORNEFERT-JENSEN, F., MARGALITH, M., BARNHART, K., NOLASCO, M., VAHLSING, H.L., MEEK, J., MARQUET, M., HOBART, P., NORMAN, J., and MANTHORPE, M. (1996). An improved plasmid DNA expression vector for direct injection into skeletal muscle. Hum. Gene Ther. 7, 1205-1217.
20. HUANG, M.T., and GORMAN, C.M. (1990). Intervening sequences increase efficiency of RNA 3′ processing and accumulation of cytoplasmic RNA. Nucleic Acids Res. 18, 937-947.
21. JIAO, S., ACSADI, G., JANI, A., FELGNER, P.L., and WOLFF, J.A. (1992). Persistence of plasmid DNA and expression in rat brain cells in vivo. Exp. Neurol. 115, 400-413.
22. KORFHAGEN, T.R., GLASSER, S.W., WERT, S.E., BRUNO, M.D., DAUGHERTY, C.C., MCNEISH, J.D., STOCK, J.L., POTTER, S.S., and WHITSETT, J.A. (1990). Cis-acting sequences from a human surfactant protein gene confer pulmonary-specific gene expression in transgenic mice. Proc. Natl. Acad. Sci. USA 87, 6122-6126.
23. KUMAR, R., FIRAK, T.A., SCHROLL, C.T., and SUBRAMANIAN, K.N. (1986). Activation of gene expression is adversely affected at high multiplicities of linked simian virus 40 enhancer. Proc. Natl. Acad. Sci. USA 83, 3199-3203.
24. LEE, E.R., MARSHALL, J., SIEGEL, C.S., JIANG, C., YEW, N.S., NICHOLS, M., NIETUPSKI, J., ZIEGLER, R.J., LANE, M., WANG, K.X., WAN, N.C., SCHEULE, R.K., HARRIS, D.J., SMITH, A.E., and CHENG, S.H. (1996). Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum. Gene Ther. 7, 1701-1717.
25. LEVITT, N., BRIGGS, D., GIL, A., and PROUDFOOT, N.J. (1989). Definition of an efficient synthetic poly(A) site. Genes & Dev. 3, 1019-1025.
26. LEWIS, J.G., LIN, K.Y., KOTHAVALE, A., FLANAGAN, W.M., MATTEUCCI, M.D., DEPRINCE, R.B., MOOK, R., JR., HENDREN, R.W., and WAGNER, R.W. (1996). A serum-resistant cytofectin for cellular delivery of antisense oligodeoxynucleotides and plasmid DNA. Proc. Natl. Acad. Sci. USA 93, 3176-3181.
27. LIANG, X., HARTIKKA, J., SUKHU, L., MANTHORPE, M., and HOBART, P. (1996). Novel, high expressing and antibiotic-controlled plasmid vectors designed for use in gene therapy. Gene Ther. 3, 350-356.
28. LIU, B., and STINSKI, M.F. (1992). Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATFand AP-1 cis-acting elements. J. Virol. 66, 4434-4444.
29. LIU, Y., LIGGITT, D., ZHONG, W., TU, G., GAENSLER, K., and DEBS, R. (1995). Cationic liposome-mediated intravenous gene delivery. J. Biol. Chem. 270, 24864-24870.
30. NAKAMURA, H., YOSHIMURA, K., JAFFE, H.A., and CRYSTAL, R.G. (1991). Interleukin-8 gene expression in human bronchial epithelial cells. J. Biol. Chem. 266, 19611-19617.
31. NIWA, M., ROSE, S.D., and BERGET, S.M. (1990). In vitro polyadenylation is stimulated by the presence of an upstream intron. Genes & Dev. 4, 1552-1559.
32. REMY, J.S., SIRLIN, C., VIERLING, P., and BEHR, J.P. (1994). Gene transfer with a series of lipophilic DNA-binding molecules. Bioconjug. Chem. 5, 647-654.
33. RIORDAN, J.R., ROMMENS, J.M., KEREM, B., ALON, N., ROZMAHEL, R., GRZELCZAK, Z., ZIELENSKI, J., LOK, S., PLAVSIC, N., CHOU, J.L., DRUMM, M.L., IANNUZI, M.C., COLLINS, F.S., and TSUI, L.C. (1989). Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245, 1066-1073.
34. SADOWSKI, I., MA, J., TRIEZENBERG, S., and PTASHNE, M. (1988). GAL4-VP16 is an unusually potent transcriptional activator. Nature 335, 563-564.
35. SAN, H., YANG, Z.Y., POMPILI, V.J., JAFFE, M.L., PLAUTZ, G.E., XU, L., FELGNER, J.H., WHEELER, C.J., FELGNER, P.L., GAO, X., HUANG, L., GORDON, D., NABEL, G.J., and NABEL, E.G. (1993). Safety and short-term toxicity of a novel cationic lipid formulation for human gene therapy. Hum. Gene Ther. 4, 781-788.
36. SHOCKETT, P., DIFILIPPANTONIO, M., HELLMAN, N., and SCHATZ, D.G. (1995). A modified tetracycline-regulated system provides autoregulatory, inducible gene expression in cultured cells and transgenic mice. Proc. Natl. Acad. Sci. USA 92, 6522-6526.
37. SOLODIN, I., BROWN, C.S., BRUNO, M.S., CHOW, C.Y., JANG, E.H., DEBS, R.J., and HEATH, T.D. (1995). A novel series of amphiphilic imidazolinium compounds for in vitro and in vivo gene delivery. Biochemistry 34, 13537-13544.
38. SORSCHER, E.J., LOGAN, J.J., FRIZZELL, R.A., LYRENE, R.K., BEBOK, Z., DONG, J.Y., DUVALL, M.D., FELGNER, P.L., MATALON, S., WALKER, L., and WIATRAK, B.J. (1994). Gene therapy for cystic fibrosis using cationic liposome mediated gene transfer: A phase I trial of safety and efficacy in the nasal airway. Hum. Gene Ther. 5, 1259-1277.
39. STRIPP, B.R., SAWAYA, P.L., LUSE, D.S., WIKENHEISER, K.A., WERT, S.E., HUFFMAN, J.A., LATTIER, D.L., SINGH, G., KATYAL, S.L., and WHITSETT, J.A. (1992). cis-acting elements that confer lung epithelial cell expression of the CC10 gene. J. Biol. Chem. 267, 14703-14712.
40. TSAN, M.F., WHITE, J.E., and SHEPARD, B. (1995). Lung-specific direct in vivo gene transfer with recombinant plasmid DNA. Am. J. Physiol. 268, L1052-L1056.
41. WANG, Y., O'MALLEY, B., JR., TSAI, S.Y., and O'MALLEY, B.W. (1994). A regulatory system for use in gene transfer. Proc. Natl. Acad. Sci. USA 91, 8180-8184.
42. WELSH, M.J., TSUI, L.-C., BOAT, T.F., and BEAUDET, A.L. (1995). Cystic Fibrosis. In The Metabolic and Molecular Bases of Inherited Disease. C.R. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, eds. (McGraw-Hill, Inc., New York) pp. 3799-3876.
43. WESTWOOD, J.A., JONES, I.M., and BISHOP, D.H. (1993). Analyses of alternative poly(A) signals for use in baculovirus expression vectors. Virology 195, 90-99.
44. WOLFF, J.A., LUDTKE, J.J., ACSADI, G., WILLIAMS, P., and JANI, A. (1992). Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum. Mol. Genet. 1, 363-369.
45. WONG, G.G., WITEK, J.S., TEMPLE, P.A., WILKENS, K.M., LEARY, A.C., LUXENBERG, D.P., JONES, S.S., BROWN, E.L., KAY, R.M., ORR, E.C., SHOEMAKER, C., GOLDE, D.W., KAUFMAN, R.J., HEWICK, R.M., WANG, E.A. and CLARK, S.C. (1985). Human GM-CSF: molecular cloning of the complementary DNA and purification of the natural and recombinant proteins. Science 228, 810-815.
46. YANKASKAS, J.R., HAIZLIP, J.E., CONRAD, M., KOVAL, D., LAZAROWSKI, E., PARADISO, A.M., RINEHART, C., JR., SARKADI, B., SCHLEGEL, R., and BOUCHER, R.C. (1993). Papilloma virus immortalized tracheal epithelial cells retain a well-differentiated phenotype. Am. J. Physiol. 264, C1219-C1230.
47. ZABNER, J., COUTURE, L.A., GREGORY, R.J., GRAHAM, S.M., SMITH, A.E., and WELSH, M.J. (1993). Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 75, 207-216.
48. ZABNER, J., FASBENDER, A.J., MONINGER, T., POELLINGER, K.A., and WELSH, M.J. (1995). Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. 20, 18997-9007.